Histaminum 30c Allergy Relief
Histaminum Hydrochloricum
Laboratoires Boiron
Human Otc Drug
NDC 0220-2488Histaminum 30c Allergy Relief also known as Histaminum Hydrochloricum is a human otc drug labeled by 'Laboratoires Boiron'. National Drug Code (NDC) number for Histaminum 30c Allergy Relief is 0220-2488. This drug is available in dosage form of Pellet. The names of the active, medicinal ingredients in Histaminum 30c Allergy Relief drug includes Histamine Dihydrochloride - 30 [hp_C]/1 . The currest status of Histaminum 30c Allergy Relief drug is Active.
Drug Information:
| Drug NDC: | 0220-2488 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Histaminum 30c Allergy Relief |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Histaminum Hydrochloricum |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Laboratoires Boiron |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Pellet |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | HISTAMINE DIHYDROCHLORIDE - 30 [hp_C]/1
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 17 Mar, 2016 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 23 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Laboratoires Boiron
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UPC: | 0306962961244
0000100007312
|
| UPC stands for Universal Product Code. |
| UNII: | 3POA0Q644U
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 0220-2488-41 | 80 PELLET in 1 TUBE (0220-2488-41) | 17 Mar, 2016 | N/A | No |
| 0220-2488-43 | 3 TUBE in 1 PACKAGE (0220-2488-43) / 80 PELLET in 1 TUBE | 17 Mar, 2016 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose* histaminum hydrochloricum 30c hpus (0.443 mg) ... relieves allergies
Product Elements:
Histaminum 30c allergy relief histaminum hydrochloricum sucrose lactose histamine dihydrochloride histamine pellet ;
Indications and Usage:
Uses* temporarily relieves symptoms of hay fever and itching from hives provides temporary relief of allergic reactions caused by: pollen ragweed mold dust mites pet dander
Warnings:
Severe allergy warning: get emergency help immediately if you have hives along with any of the following symptoms: trouble swallowing dizziness or loss of consciousness swelling of tongue swelling in or around mouth trouble speaking drooling wheezing or problems breathing.
Do Not Use:
Severe allergy warning: get emergency help immediately if you have hives along with any of the following symptoms: trouble swallowing dizziness or loss of consciousness swelling of tongue swelling in or around mouth trouble speaking drooling wheezing or problems breathing.
Dosage and Administration:
Directions adults and children: at the onset of symptoms, dissolve 5 pellets under the tongue every 15 minutes for 1 hour. then, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.
Package Label Principal Display Panel:
Label 6704287 label box
Further Questions:
Questions, comments? www.boironusa.com info@boiron.com 1-800-boiron-1 (1-800-264-7661) distributed by boiron inc. newtown square, pa 19073-3267